Summary
- Current Price
- As of today, HIMS price is $35.47, up +11.23% on
- Current Price All-Time High
- HIMS price is currently -51.40% below its historical high of $72.98 set on
- Market Cap
- HIMS current market cap is $8B, down -39.87% year-over-year
- PE Ratio
- HIMS PE ratio is unknown
- Revenue
- HIMS current annual revenue is $2.35B, up +59.00% year-over-year
- Next Earnings
- The next earnings release for HIMS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Hims & Hers Health, Inc. |
| Ticker | NYSE: HIMS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hims.com |
| Employees | 1,637 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $35.47 | |
| Price, 1D Change | +11.23% | |
| Market Cap | $8B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.54 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +59.00% | |
| EPS | $0.51 | |
| EPS, 1Y Change | -3.74% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | OAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.51 | |
| EPS Estimate | N/A | -$0.08 |
| EPS Est. Change | N/A | -115.62% |
| Revenue | $2.35B | |
| Revenue Estimate | N/A | $3.15B |
| Revenue Est. Change | N/A | +34.26% |
| Current Price | $35.47 | |
| Price Target | - | $25.00 |
| Price Tgt. Change | - | -29.52% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.85 | $0.53 | -37.20% | |
| $0.47 | $0.51 | +8.95% | |
| -$0.08 | N/A | -115.62% | |
| $0.67 | N/A | +30.78% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.46B | $1.48B | +0.92% | |
| $2.35B | $2.35B | +0.03% | |
| $3.15B | N/A | +34.26% | |
| $4.46B | N/A | +90.07% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -41.92% | |
| Price, 3Y | +310.06% | |
| Market Cap, 1Y | -39.87% | |
| Market Cap, 3Y | +353.44% | |
| Revenue, 1Y | +59.00% | |
| Revenue, 3Y | +345.54% | |
| EPS, 1Y | -3.74% | |
| EPS, 3Y | +259.55% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $35.47 | |
| SMA 200 | $33.36 | |
| SMA 50 | $26.64 | |
| EMA 200 | $30.53 | |
| EMA 50 | $26.73 | |
| $1.80 | ||
| Beta | 2.54 | |
| ATR | $2.35 | |
| 14-Day RSI | 71.07 | |
| 10-Day Volatility | 108.27% | |
| 1-Year Volatility | 97.83% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.35B | |
| EPS | $0.51 | |
| Gross Profit | $1.39B | |
| Gross Margin | 59.31% | |
| Operating Income | $121.69M | |
| Operating Margin | 5.18% | |
| Net Income | $128.37M | |
| Net Margin | 5.47% | |
| EBITDA | $176.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.07 | |
| 1.90 | ||
| 1.61 | ||
| - | ||
| 3 | ||
| 4.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 3.46 | ||
| 18.40 | ||
| 74.40 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $540.93M | |
| $577.49M | ||
| $2.15B | ||
| $767.64M | ||
| $1.61B | ||
| $404.43M | ||
| Total Debt | $1.12B | |
| $4.84M | ||
| $143.28M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.22B | ||
| $1.27B | ||
| $955.21M | ||
| $0.00 | ||
| $54.50M | ||
| $0.00 | ||
| -$4.44M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $300.01M | ||
| -$1.02B | ||
| $729.62M | ||
| Capex | $242.59M | |
| $57.42M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B of A Securities | → | |
| Truist Securities | → | |
| B of A Securities | → | |
| B of A Securities | → | |
| Needham | → | |
| JP Morgan | → | |
| Citigroup | → | |
| BTIG | → | |
| JP Morgan | ||
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with HIMS
FAQ
What is the ticker symbol for Hims & Hers Health, Inc.?
The ticker symbol for Hims & Hers Health, Inc. is NYSE:HIMS
Does Hims & Hers Health, Inc. pay dividends?
No, Hims & Hers Health, Inc. does not pay dividends
What sector is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is in the Healthcare sector
What industry is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Hims & Hers Health, Inc. based in?
Hims & Hers Health, Inc. is headquartered in United States
When did Hims & Hers Health, Inc. go public?
Hims & Hers Health, Inc. initial public offering (IPO) was on September 13, 2019
Is Hims & Hers Health, Inc. in the S&P 500?
No, Hims & Hers Health, Inc. is not included in the S&P 500 index
Is Hims & Hers Health, Inc. in the NASDAQ 100?
No, Hims & Hers Health, Inc. is not included in the NASDAQ 100 index
Is Hims & Hers Health, Inc. in the Dow Jones?
No, Hims & Hers Health, Inc. is not included in the Dow Jones index
When was Hims & Hers Health, Inc. last earnings report?
Hims & Hers Health, Inc.'s most recent earnings report was on May 11, 2026
When does Hims & Hers Health, Inc. report earnings?
The next expected earnings date for Hims & Hers Health, Inc. is August 10, 2026
Data Sources & References
- HIMS Official Website www.hims.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1773751/000177375126000022/0001773751-26-000022-index.htm
- HIMS Profile on Yahoo Finance finance.yahoo.com/quote/HIMS
- HIMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hims